When you join MSK Healthy Living, our experts will create a personal lifestyle plan for you. First, you will fill out a questionnaire that asks you questions about your goals and needs. The survey is ...

Discover the joys of crafting your very own DIY terrarium and transform your space into a green oasis! Whether this is your first time or you are a crafty botanical enthusiasts, this virtual workshop ...

En esta información se explica qué son el síndrome de liberación de citocinas y el síndrome de neurotoxicidad. También se describen las causas, los síntomas y los tratamientos comunes de cada enfermed ...

New research from Memorial Sloan Kettering Cancer Center (MSK) finds improving intestinal metabolism may help treat chronic inflammation and prevent cancer; shows how breast cancer resistance is ...

This most recent clinical trial examined whether participating in virtually delivered, live classes including yoga, tai chi, meditation, fitness, and other integrative therapies could benefit patients ...

Sayantan grew up in Elmont, NY and is studying biochemistry and bioinformatics at The University of Houston. After completing his bachelor's degree, he plans to pursue a PhD. He is interested in ...

Researchers at Memorial Sloan Kettering Cancer Center (MSK), the University of California, San Francisco (UCSF), and University of California, Berkeley (UC Berkeley) have developed an artificial ...

Researchers from Memorial Sloan Kettering Cancer Center (MSK) reported important advances in the treatment of lung cancer at the annual meeting of the American Society of Clinical Oncology (ASCO), ...

When cancer spreads from a primary tumor to new sites throughout the body, it undergoes changes that increase its genetic complexity. A new study from researchers at Memorial Sloan Kettering Cancer ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat ...

For decades, cancers with mutations in the gene KRAS (KAY-ras) were considered “undruggable.” KRAS mutations are found in more than 20% of cancers. They are most common in lung cancer, pancreatic ...

An approach pioneered at Memorial Sloan Kettering Cancer Center (MSK) that caused rectal cancer tumors with a specific genetic mutation to disappear in 100% of clinical trial participants has been ...